Dr. Kerry Hernandez is an Associate Program Officer for the Helmsley Charitable Trust’s Crohn’s Disease Program. Kerry contributes to managing the Program’s portfolio of prevention grants, which focuses on the identification of the causes of Crohn’s disease and the development of strategies to prevent onset and recurrence and delay disease progression, with the ultimate goal of improving the lives of Crohn’s disease patients.

Before joining Helmsley, Kerry was a postdoctoral fellow in the Neurology Department at the Icahn School of Medicine at Mount Sinai where she studied molecular biology and worked on the development of therapeutics to combat neurodegenerative diseases, such as Parkinson’s and Huntington’s disease. Kerry has a Ph.D. in Pharmacology from Weill Cornell Graduate School and earned a B.A. in neuroscience from Skidmore College.